paxilline has been researched along with norcantharidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, YZ; Ge, CY; Liu, ZY; Sun, W; Wang, H; Zhang, JT; Zhang, WZ | 1 |
| Ahn, CH; Cho, SD; Han, JM; Hong, KO; Hong, SD; Shin, JA; Yang, IH | 1 |
2 other study(ies) available for paxilline and norcantharidin
| Article | Year |
|---|---|
Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Ephrin-A2; Female; Focal Adhesion Protein-Tyrosine Kinases; Gallbladder Neoplasms; Humans; Male; Mice; Microcirculation; Paxillin; Signal Transduction; Survival Analysis; Xenograft Model Antitumor Assays | 2014 |
Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
Topics: Actins; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Focal Adhesion Protein-Tyrosine Kinases; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Paxillin; Signal Transduction | 2019 |